Time in Therapeutic Range in Patients with Venous Thromboembolism on Vitamin K Antagonist in a Moroccan Thrombosis Unit : An Observational Study.

previously demonstrated that cancer significantly decreases TTR in VTE patients treated with VKAs. 27 Even in the controlled environment of clinical trials, such as CLOT and CATCH, TTR values remained low (46 and 47%, respectively). 28 29 In our study, cancer patients exhibited a lower mean TTR compared with noncancer patients, although this difference did not reach statistical significance [42.1 ± 32.9 vs. 36.1 ± 33.5, p = NS].

also in 111,027 other papers